Lv3
350 积分 2024-09-16 加入
Tirzepatide: First Approval
8天前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
20天前
已完结
Dozens of new obesity drugs are coming: these are the ones to watch
23天前
已完结
Transforming obesity: The advancement of multi-receptor drugs
25天前
已完结
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease
1个月前
已完结
GDF15 promotes weight loss by enhancing energy expenditure in muscle
1个月前
已完结
Glucagon-like peptide-1 analogs: Miracle drugs are blooming?
1个月前
已完结
Acute kidney injury
1个月前
已完结
A researcher’s guide to preclinical mouse NASH models
1个月前
已完结
An optimized procedure to record visual evoked potential in mice
2个月前
已完结
皖公网安备34019202002308
